These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16439123)

  • 21. Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSP.
    Rickert KW; Schaber M; Torrent M; Neilson LA; Tasber ES; Garbaccio R; Coleman PJ; Harvey D; Zhang Y; Yang Y; Marshall G; Lee L; Walsh ES; Hamilton K; Buser CA
    Arch Biochem Biophys; 2008 Jan; 469(2):220-31. PubMed ID: 17999913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and SAR of thiophene containing kinesin spindle protein (KSP) inhibitors.
    Pinkerton AB; Lee TT; Hoffman TZ; Wang Y; Kahraman M; Cook TG; Severance D; Gahman TC; Noble SA; Shiau AK; Davis RL
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3562-9. PubMed ID: 17498954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential new chemotherapy strategy for human ovarian carcinoma with a novel KSP inhibitor.
    Takenaga M; Yamamoto Y; Takeuchi T; Ohta Y; Tokura Y; Hamaguchi A; Asai D; Nakashima H; Oishi S; Fujii N
    Biochem Biophys Res Commun; 2015 Jul; 463(3):222-8. PubMed ID: 25998394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and SAR of pyrrolotriazine-4-one based Eg5 inhibitors.
    Kim KS; Lu S; Cornelius LA; Lombardo LJ; Borzilleri RM; Schroeder GM; Sheng C; Rovnyak G; Crews D; Schmidt RJ; Williams DK; Bhide RS; Traeger SC; McDonnell PA; Mueller L; Sheriff S; Newitt JA; Pudzianowski AT; Yang Z; Wild R; Lee FY; Batorsky R; Ryder JS; Ortega-Nanos M; Shen H; Gottardis M; Roussell DL
    Bioorg Med Chem Lett; 2006 Aug; 16(15):3937-42. PubMed ID: 16730979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3D-QSAR studies of dihydropyrazole and dihydropyrrole derivatives as inhibitors of human mitotic kinesin Eg5 based on molecular docking.
    Luo X; Shu M; Wang Y; Liu J; Yang W; Lin Z
    Molecules; 2012 Feb; 17(2):2015-29. PubMed ID: 22343406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent progress in the identification and clinical evaluation of inhibitors of the mitotic kinesin KSP.
    Knight SD; Parrish CA
    Curr Top Med Chem; 2008; 8(10):888-904. PubMed ID: 18673173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinesin spindle protein (KSP) inhibitors in combination with chemotherapeutic agents for cancer therapy.
    Song H; Zhou S; Wang R; Li S
    ChemMedChem; 2013 Nov; 8(11):1736-49. PubMed ID: 23964020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Synthesis and antitumor activity of novel tetrahydro-beta-carboline derivatives as KSP inhibitors].
    Ruan XQ; Chen M; Wu WT; You QD
    Yao Xue Xue Bao; 2013 Jul; 48(7):1119-23. PubMed ID: 24133978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of biphenyl compounds as kinesin spindle protein inhibitors.
    Holland JP; Kang A; Cohrs S; Selivanova SV; Milicevic Sephton S; Betzel T; Frey D; Wieser M; Jaussi R; Kammerer RA; Schibli R; Fischer E
    Chem Biodivers; 2013 Apr; 10(4):538-55. PubMed ID: 23576341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel ATP-competitive kinesin spindle protein inhibitors.
    Parrish CA; Adams ND; Auger KR; Burgess JL; Carson JD; Chaudhari AM; Copeland RA; Diamond MA; Donatelli CA; Duffy KJ; Faucette LF; Finer JT; Huffman WF; Hugger ED; Jackson JR; Knight SD; Luo L; Moore ML; Newlander KA; Ridgers LH; Sakowicz R; Shaw AN; Sung CM; Sutton D; Wood KW; Zhang SY; Zimmerman MN; Dhanak D
    J Med Chem; 2007 Oct; 50(20):4939-52. PubMed ID: 17725339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of kinesin spindle protein inhibitor-induced cell death by modulation of mitochondrial and death receptor apoptotic pathways.
    Vijapurkar U; Wang W; Herbst R
    Cancer Res; 2007 Jan; 67(1):237-45. PubMed ID: 17210704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dihydropyrazole and dihydropyrrole structures based design of Kif15 inhibitors as novel therapeutic agents for cancer.
    Sebastian J
    Comput Biol Chem; 2017 Jun; 68():164-174. PubMed ID: 28355588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationships of carboline and carbazole derivatives as a novel class of ATP-competitive kinesin spindle protein inhibitors.
    Takeuchi T; Oishi S; Watanabe T; Ohno H; Sawada J; Matsuno K; Asai A; Asada N; Kitaura K; Fujii N
    J Med Chem; 2011 Jul; 54(13):4839-46. PubMed ID: 21599002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of N-(1-(6-acetamido-5-phenylpyrimidin-4-yl) piperidin-3-yl) amide derivatives as potential inhibitors for mitotic kinesin spindle protein.
    Muthuraja P; Himesh M; Prakash S; Venkatasubramanian U; Manisankar P
    Eur J Med Chem; 2018 Mar; 148():106-115. PubMed ID: 29454915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Docking studies on kinesin spindle protein inhibitors: an important cooperative 'minor binding pocket' which increases the binding affinity significantly.
    Jiang C; Chen Y; Wang X; You Q
    J Mol Model; 2007 Sep; 13(9):987-92. PubMed ID: 17588180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-Drug Conjugates with Pyrrole-Based KSP Inhibitors as the Payload Class.
    Lerchen HG; Wittrock S; Stelte-Ludwig B; Sommer A; Berndt S; Griebenow N; Rebstock AS; Johannes S; Cancho-Grande Y; Mahlert C; Greven S; Terjung C
    Angew Chem Int Ed Engl; 2018 Nov; 57(46):15243-15247. PubMed ID: 30180286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinesin spindle protein inhibitors with diaryl amine scaffolds: crystal packing analysis for improved aqueous solubility.
    Takeuchi T; Oishi S; Kaneda M; Ohno H; Nakamura S; Nakanishi I; Yamane M; Sawada J; Asai A; Fujii N
    ACS Med Chem Lett; 2014 May; 5(5):566-71. PubMed ID: 24900881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional 1,3a,6a-triazapentalene scaffold: Design of fluorescent probes for kinesin spindle protein (KSP).
    Sawada JI; Osawa A; Takeuchi T; Kaneda M; Oishi S; Fujii N; Asai A; Tanino K; Namba K
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5765-5769. PubMed ID: 27793568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinesin spindle protein inhibitors in cancer: a patent review (2008 - present).
    Jiang C; You Q
    Expert Opin Ther Pat; 2013 Dec; 23(12):1547-60. PubMed ID: 23978071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and evaluation of tetrahydroisoquinolines as new kinesin spindle protein inhibitors.
    Jiang C; You Q; Liu F; Wu W; Guo Q; Chern J; Yang L; Chen M
    Chem Pharm Bull (Tokyo); 2009 Jun; 57(6):567-71. PubMed ID: 19483335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.